Literature DB >> 6208407

[Ascites as a complication of hepatic storage of hydroxyethyl starch in long-term dialysis].

U Pfeifer, J Kult, H Förster.   

Abstract

Three adult dialysis patients developed ascites after having received repeatedly the plasma substitute hydroxyethyl starch (HES 40/0.5). In two cases (total dose 180, and 330 g HES, respectively) the ascites was reversible after discontinuation of the HES administration. In the third case (total dose 915 g HES) the ascites could be controlled only by implantation of a Denver shunt. In this latter case it was shown by histological, electron microscopical, and biochemical findings that the ascites was caused by hepatic sinusoidal obstruction due to an extreme storage of HES in the sinusoidal lining cells. Additional storage was detected in hepatocytes, bile duct epithelia, endothelial cells, and fibroblasts in the portal tracts. Biochemically HES was found in liver tissue at a concentration of 4% (w/w). Although in renal impairment plasma clearance of HES is not significantly different from normal individuals, long-term administration of HES must be regarded inadvisable because of tissue storage which apparently is especially significant in this condition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208407     DOI: 10.1007/bf01712005

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  12 in total

1.  Histological changes produced by injections of polysaccharides.

Authors:  M WOLMAN
Journal:  AMA Arch Pathol       Date:  1956-08

2.  Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch.

Authors:  W L Thompson; T Fukushima; R B Rutherford; R P Walton
Journal:  Surg Gynecol Obstet       Date:  1970-11

3.  [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].

Authors:  J M Mishler
Journal:  Infusionsther Klin Ernahr       Date:  1980-04

4.  [Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods].

Authors:  H Förster; C Wicarkzyk; R Dudziak
Journal:  Infusionsther Klin Ernahr       Date:  1981-04

Review 5.  Hetastarch: an overview of the colloid and its metabolism.

Authors:  J D Hulse; A Yacobi
Journal:  Drug Intell Clin Pharm       Date:  1983-05

6.  Iatrogenic multiorgan silicone inclusions in dialysis patients.

Authors:  J Bommer; R Waldherr; M Gastner; R Lemmes; E Ritz
Journal:  Klin Wochenschr       Date:  1981-10-15

7.  [Reply to W. L. Thompson's commentary (Infusionstherapie 4:56-62 1977) on G. Lindblad's and J. Falk's study on "Course of hydroxyethyl starch and dextran concentration in blood and liver of rabbits and the histopathological consequences of hydroxyethyl starch storage (Infusionstherapie 3:301-3 1976)].

Authors: 
Journal:  Infusionsther Klin Ernahr       Date:  1978-04

8.  [Effect of kidney function on the elimination and action of colloidal plasma substitutes].

Authors:  H Köhler
Journal:  Fortschr Med       Date:  1979-10-25

9.  [Hydroxyethyl starch (HAS 450/0.7) in human plasma and liver. Course of concentration and histological changes].

Authors:  F Jesch; G Hübner; V Zumtobel; M Zimmermann; K Messmer
Journal:  Infusionsther Klin Ernahr       Date:  1979-04

10.  [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].

Authors:  J M Mishler; M Beez
Journal:  Infusionsther Klin Ernahr       Date:  1979-04
View more
  5 in total

Review 1.  Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.

Authors:  Romuald Bellmann; Clemens Feistritzer; Christian J Wiedermann
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

2.  [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].

Authors:  H Kiesewetter; F Jung; J Blume; B Bulling; R P Franke
Journal:  Klin Wochenschr       Date:  1986-01-02

Review 3.  Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review.

Authors:  Christian J Wiedermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2013-11-21       Impact factor: 17.440

Review 4.  [Hydroxyethylstarch (HES)].

Authors:  Joachim Boldt
Journal:  Wien Klin Wochenschr       Date:  2004-03-31       Impact factor: 2.275

5.  Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis.

Authors:  Christian J Wiedermann
Journal:  BMC Emerg Med       Date:  2008-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.